Literature DB >> 4187537

Therapy with progestational agents in advanced benign prostatic hypertrophy.

J Geller, A Angrist, K Nakao, H Newman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 4187537

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  Evaluation of Depostat in prostatic adenoma on the ground of clinical and sphincterotonometric studies.

Authors:  D Makrigiannis; A Gaca
Journal:  Int Urol Nephrol       Date:  1971       Impact factor: 2.370

2.  Shrinking the prostate.

Authors: 
Journal:  Br Med J       Date:  1970-03-07

3.  Rapatar, a nanoformulation of rapamycin, decreases chemically-induced benign prostate hyperplasia in rats.

Authors:  Ekaterina A Lesovaya; Kirill I Kirsanov; Elena E Antoshina; Lubov S Trukhanova; Tatiana G Gorkova; Elena V Shipaeva; Ramiz M Salimov; Gennady A Belitsky; Mikhail V Blagosklonny; Marianna G Yakubovskaya; Olga B Chernova
Journal:  Oncotarget       Date:  2015
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.